Enterprise Value

1.042B

Cash

176.6M

Avg Qtr Burn

-51.71M

Short % of Float

0.07%

Insider Ownership

0.00%

Institutional Own.

0.74%

Qtr Updated

03/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
IXCHIQ (VLA1553) Details
Chikungunya, Infectious disease

Approved

Quarterly sales

IXCHIQ (VLA1553) Details
Chikungunya, Viral infection

Phase 3

Update

IXCHIQ (VLA1553) Details
Chikungunya, Viral infection

Phase 3

Initiation

IXCHIQ (VLA1553) Details
Chikungunya, Viral infection

Phase 2

Data readout

VLA15 Details
Bacterial infection, Lyme disease

Phase 2

Data readout

VLA1601 Details
Viral infection, Zika virus

Phase 1

Data readout

VLA2001 Details
Infectious disease, COVID-19

Failed

Discontinued